Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

To streamline early discovery, a cross-disciplinary, data-driven workflow process is key

Posted on February 23rd, 2018 by in Pharma R&D

“Complex” is the term that best describes the conditions that affect us. Whether it’s a disease or a consequence of a natural process such as aging, there are no simple fixes. Continue reading “To streamline early discovery, a cross-disciplinary, data-driven workflow process is key” »

Does Chemistry Have an Image Problem?

Posted on October 6th, 2017 by in Chemistry

The results of a recent study on chemistry research, conducted by Elsevier’s Reaxys team, suggest that chemistry might need to work on its image. Continue reading “Does Chemistry Have an Image Problem?” »

Is the Pharma Industry Missing the Big Picture?

Posted on September 22nd, 2017 by in Pharma R&D

There is a disconnect between how drugs are developed and how they are used. In the traditional method of target-oriented development, each new candidate drug is scrutinized in a handful of interactions with desirable and undesirable targets. Continue reading “Is the Pharma Industry Missing the Big Picture?” »

Introducing e-Therapeutics: An In Silico Drug Discovery Lab

Posted on May 1st, 2017 by in Chemistry

When laypeople think of drug development, they almost certainly imagine clinical labs filled with chemistry and biology labware or trials with control and test groups receiving different doses of the proposed new treatments. Continue reading “Introducing e-Therapeutics: An In Silico Drug Discovery Lab” »

  1. 1
  2. 2